Breathing vest tested for hospital patients – but study stopped early
NCT ID NCT06108284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a negative pressure vest (Biphasic Cuirass Ventilation) to see if it works as well as standard breathing masks for patients hospitalized with acute hypercapnic respiratory failure (high carbon dioxide levels). The trial planned to enroll 50 adults, but it was terminated early. Because of this, we cannot draw firm conclusions about the device's effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biphasic cuirass ventilation (a negative pressure vest)
- What this could lead to
- If it worked, this device could offer an alternative to standard breathing masks for patients with acute breathing failure.
- What could go wrong
- The trial was terminated early with only 50 participants, so we don't have enough data to know if it works. The device also has specific risks for people with chest injuries or prior surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE HYPERCAPNIC RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Missouri Hospitals
Columbia, Missouri, 65212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.